24 Stocks Moving in Thursday's Pre-Market Session

Gainers

• Acorda Therapeutics, Inc. (NASDAQ:ACOR) shares rose 20.9% to $0.70 in pre-market trading after dropping 12% on Wednesday. Acorda Therapeutics recently posted a Q1 loss of $1.66 per share.
• GreenBox POS (NASDAQ:GBOX) rose 19.2% to $2.67 in pre-market trading after jumping around 12% on Wednesday. GreenBox POS recently posted Q1 sales of $4.90 million.
• Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) rose 16.2% to $0.2522 in pre-market trading after climbing over 20% on Wednesday. Salarius Pharmaceuticals recently posted a Q1 loss of $0.13 per share.
• Genocea Biosciences, Inc. (NASDAQ:GNCA) rose 15.7% to $0.28 in pre-market trading after gaining around 8% on Wednesday.
• Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) rose 10.5% to $0.4380 in pre-market trading after dipping around 19% on Wednesday.
• Snow Lake Resources Ltd. (NASDAQ:LITM) shares rose 9.8% to $3.59 in pre-market trading.
• AIM ImmunoTech Inc. (NYSE:AIM) rose 9.5% to $0.9765 in pre-market trading after declining 6% on Wednesday.
• AIM ImmunoTech recently posted a Q1 loss of $0.08 per share.
• First Wave BioPharma, Inc. (NASDAQ:FWBI) shares rose 9.5% to $0.4399 in pre-market trading after jumping around 14% on Wednesday. First Wave BioPharma recently reported data from its Phase 2 RESERVOIR trial of FW-COV, which showed FW-COV's ability to remove the SARS-CoV-2 virus from the digestive tract did not demonstrate statistical significance.
• Kodiak Sciences Inc. (NASDAQ:KOD) shares rose 7.5% to $6.45 in pre-market trading. Kodiak Sciences recently posted a Q1 loss of $1.83 per share.
• Armstrong Flooring, Inc. (NYSE:AFI) rose 7.4% to $0.4620 in pre-market trading. Armstrong Flooring shares jumped 46% on Wednesday after receiving approval for additional financing.
• Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) rose 7.4% to $3.35 in pre-market trading as the company reported its flagship brand experience center in Beverly Hills, Calif., and its selection of ASTOUND Group for experience design and execution.
• Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) rose 7.1% to $0.7462 in pre-market trading.
• Sociedad Química y Minera de Chile S.A. (NYSE:SQM) rose 6.5% to $96.03 in pre-market trading after reporting net income of US$796.1 million for the three months ended March 31, 2022.

Don’t forget to check out our premarket coverage here .

Losers

• Nerdy, Inc. (NYSE:NRDY) shares fell 31.8% to $1.18 in pre-market trading after dipping more than 10% on Wednesday. The company recently posted upbeat quarterly sales.
• Bright Green (NASDAQ:BGXX) shares fell 14.9% to $40.94 in pre-market trading after jumping 90% on Wednesday. Bright Green, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to list on a major U.S. stock exchange.
• Cisco Systems, Inc. (NASDAQ:CSCO) fell 13.9% to $41.66 in pre-market trading. Cisco reported upbeat earnings for its third quarter, while sales missed estimates. The company also issued weak Q4 and FY22 earnings guidance.
• TC Biopharm (Holdings) Plc (NASDAQ:TCBP) shares fell 13.5% to $0.9513 in pre-market trading after jumping over 15% on Wednesday. TC BioPharm announced formation of scientific advisory board with renowned cell therapy experts.
• Vinco Ventures, Inc. (NASDAQ:BBIG) fell 12.8% to $2.66 in pre-market trading after gaining around 7% on Wednesday.
• Alset EHome International Inc. (NASDAQ:AEI) fell 10.2% to $0.3053 in pre-market trading after declining around 5% on Wednesday.
• Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) fell 8.8% to $4.56 in pre-market trading after dropping 80% on Wednesday.
• Troika Media Group, Inc. (NASDAQ:TRKA) fell 8.4% to $0.5292 in pre-market trading after surging 52% on Wednesday.
• Guardforce AI Co., Limited (NASDAQ:GFAI) fell 8.3% to $0.55 in pre-market trading.
• Appian Corporation (NASDAQ:APPN) fell 7.5% to $45.16 in pre-market trading after dropping 6% on Wednesday.
• Juniper Networks, Inc. (NYSE:JNPR) shares fell 5.8% to $28.11 in pre-market trading. Juniper Networks, last month, reported worse-than-expected Q1 adjusted EPS results.